Both vitamins are involved in pathways relevant to sarcopenia pathophysiology, including Nuclear factor-κB (NF-κB) signaling, Nrf2 antioxidant responses, and protein kinase B (AKT)/ mechanistic target of rapamycin (mTOR)-mediated protein turnover [28,29,30,31]. The gene discussed is MTOR; the disease is sarcopenia.